These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 33755615)
21. Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum. Uriu K; Kimura I; Shirakawa K; Takaori-Kondo A; Nakada TA; Kaneda A; Nakagawa S; Sato K; N Engl J Med; 2021 Dec; 385(25):2397-2399. PubMed ID: 34731554 [No Abstract] [Full Text] [Related]
22. Convalescent plasma for coronavirus disease 2019 in pregnancy: a case report and review. Grisolia G; Franchini M; Glingani C; Inglese F; Garuti M; Beccaria M; Capuzzo M; Pinto A; Pavan G; Righetto L; Perotti C; Zampriolo P; De Donno G Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100174. PubMed ID: 32838270 [No Abstract] [Full Text] [Related]
23. Antibodies, epicenter of SARS-CoV-2 immunology. Pecetta S; Pizza M; Sala C; Andreano E; Pileri P; Troisi M; Pantano E; Manganaro N; Rappuoli R Cell Death Differ; 2021 Feb; 28(2):821-824. PubMed ID: 33500559 [No Abstract] [Full Text] [Related]
24. Passive immunization and its rebirth in the era of the COVID-19 pandemic. Pavia CS; Wormser GP Int J Antimicrob Agents; 2021 Mar; 57(3):106275. PubMed ID: 33400975 [TBL] [Abstract][Full Text] [Related]
25. [Is convalescent plasma an alternative treatment for Covid-19 patients?]. Trejo-Gómor JE; Dimas-González J; Lagunas-Martínez A Salud Publica Mex; 2020; 62(6):870-871. PubMed ID: 33620985 [No Abstract] [Full Text] [Related]
26. Audio Interview: New Studies of Covid-19 Transmission. Rubin EJ; Baden LR; Morrissey S N Engl J Med; 2020 Nov; 383(22):e138. PubMed ID: 33252875 [No Abstract] [Full Text] [Related]
27. COVID-19: Herd immunity and convalescent plasma transfer therapy. Syal K J Med Virol; 2020 Sep; 92(9):1380-1382. PubMed ID: 32281679 [No Abstract] [Full Text] [Related]
28. International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary. Al-Riyami AZ; Burnouf T; Yazer M; Triulzi D; Kumaş LT; Sağdur L; Pelit NB; Bazin R; Hindawi SI; Badawi MA; Patidar GK; Pandey HC; Chaurasia R; Fachini RM; Scuracchio P; Wendel S; Ang AL; Ong KH; Young P; Ihalainen J; Vierikko A; Qiu Y; Yang R; Xu H; Rahimi-Levene N; Shinar E; Izak M; Gonzalez CA; Ferrari DM; Cini PV; Aditya RN; Sharma RR; Sachdev S; Hans R; Lamba DS; Nissen-Meyer LSH; Devine DV; Lee CK; Leung JN; Hung IFN; Tiberghien P; Gallian P; Morel P; Al Maamari K; Al-Hinai Z; Vrielink H; So-Osman C; De Angelis V; Berti P; Ostuni A; Marano G; Nevessignsky MT; El Ekiaby M; Daly J; Hoad V; Kim S; van den Berg K; Vermeulen M; Glatt TN; Schäfer R; Reik R; Gammon R; Lopez M; Estcourt L; MacLennan S; Roberts D; Louw V; Dunbar N; Vox Sang; 2021 Nov; 116(10):1117-1135. PubMed ID: 34013968 [No Abstract] [Full Text] [Related]
29. SARS-CoV-2 variants: a new challenge to convalescent serum and mRNA vaccine neutralization efficiency. Li M; Lou F; Fan H Signal Transduct Target Ther; 2021 Apr; 6(1):151. PubMed ID: 33839737 [No Abstract] [Full Text] [Related]
30. Convalescent Plasma: A Potential Life-Saving Therapy for Coronavirus Disease 2019 (COVID-19). Alghamdi AN; Abdel-Moneim AS Front Public Health; 2020; 8():437. PubMed ID: 32903641 [No Abstract] [Full Text] [Related]
31. Once Viewed as a Promising COVID-19 Treatment, Convalescent Plasma Falls Out of Favor. Rubin R JAMA; 2022 Mar; 327(12):1115-1116. PubMed ID: 35262639 [No Abstract] [Full Text] [Related]
32. In the Limelight: September 2020. Nath KA Mayo Clin Proc; 2020 Sep; 95(9):1813-1815. PubMed ID: 32861318 [No Abstract] [Full Text] [Related]
33. Measuring accuracy of the neutralizing activity of COVID-19 convalescent plasma. Franchini M; Mengoli C; Caruso B; Petilino R; Ballotari A; Glingani C Clin Chem Lab Med; 2022 Jan; 60(1):e4-e6. PubMed ID: 34472761 [No Abstract] [Full Text] [Related]
34. [Building the scientific commons. Conflictualities and pluralism in the light of clinical trials Covid-19]. Israel-Jost V; Coutellec L Med Sci (Paris); 2021 Jan; 37(1):89-96. PubMed ID: 33492224 [TBL] [Abstract][Full Text] [Related]
35. Evidence for antibody as a protective correlate for COVID-19 vaccines. Earle KA; Ambrosino DM; Fiore-Gartland A; Goldblatt D; Gilbert PB; Siber GR; Dull P; Plotkin SA Vaccine; 2021 Jul; 39(32):4423-4428. PubMed ID: 34210573 [TBL] [Abstract][Full Text] [Related]
36. Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee. Patel MM; Thornburg NJ; Stubblefield WB; Talbot HK; Coughlin MM; Feldstein LR; Self WH JAMA; 2020 Nov; 324(17):1781-1782. PubMed ID: 32940635 [TBL] [Abstract][Full Text] [Related]
37. Rapid recovery of taste and smell in a patient with SARS-CoV-2 following convalescent plasma therapy. Fisher DL; Pavel A; Malnick S QJM; 2021 Aug; 114(5):319-320. PubMed ID: 33416888 [No Abstract] [Full Text] [Related]
38. Vaccines, convalescent plasma, and monoclonal antibodies for covid-19. Sewell HF; Agius RM; Kendrick D; Stewart M BMJ; 2020 Jul; 370():m2722. PubMed ID: 32646867 [No Abstract] [Full Text] [Related]
39. Convalescent Plasma for Covid-19 - Making Sense of the Inconsistencies. Estcourt L; Callum J N Engl J Med; 2022 May; 386(18):1753-1754. PubMed ID: 35507487 [No Abstract] [Full Text] [Related]
40. Access considerations for a COVID-19 vaccine for South Africa. Bangalee V; Suleman F S Afr Fam Pract (2004); 2020 Oct; 62(1):e1-e4. PubMed ID: 33179954 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]